According to the results of a recent survey conducted by Decision Resources ("one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues"), 52.3 percent of newly diagnosed bipolar disorder patients are prescribed antidepressant drugs first line. (See the press release “Astonishing 52 Percent of Newly Diagnosed Bipolar Disorder Patients Receive Antidepressant Drugs in First-Line Treatment.”)